Abstract
Durable Clinical Responses in Heavily Pretreated Patients with Relapsed/Refractory Multiple Myeloma: Updated Results from a Multicenter Study of bb2121 Anti-Bcma CAR T Cell Therapy
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have